MedTrace Logo

Patello-Femoral Joint Post Market Clinical Follow-up Within the Knee Registry

NCT01469806 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2016-09-27

No results posted yet for this study

Summary

The primary objective of the Registry is to allow for tracking of FDA approved and/or cleared knees used in primary, revision, unicompartmental or partial total knee arthroplasty (TKA). Second, it is our desire to assist orthopaedic surgeons in obtaining and evaluating radiographic and functional outcomes data on their PFJ patients using current published guidelines. Third, within this Registry, subsets of data on newer technology are being collected for the purpose of future publications. The Patello-Femoral Joint Post Market Clinical (PFJ PMCF) study is one such subset.

Conditions

Interventions

DEVICE

Zimmer Gender Solutions PFJ Knee Prosthesis

Partial knee arthroplasty of the patello-femoral joint

Sponsors & Collaborators

  • Zimmer Biomet

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2023-10-31
Completion
2023-10-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01469806 on ClinicalTrials.gov